A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Name: A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Published: 2025
License: Public Domain

BeOne Medicines · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

hematological-malignancies

chronic lymphocytic leukemia, cll, mantle cell lymphoma, mcl, cll previously untreated, hematological malignancies, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Related documents